Pimecrolimus vs Ustekinumab
National NHS prescribing compared (Prescription Cost Analysis)
Pimecrolimus was dispensed 12,797.0× as often as Ustekinumab in May 2026 — 12,797 items versus 1 in England.
12,797items
Pimecrolimus · May 2026
NHSBSA Prescription Cost Analysis
1items
Ustekinumab · May 2026
NHSBSA Prescription Cost Analysis
Figure 1. Pimecrolimus versus Ustekinumab: national items dispensed by month
▬ Pimecrolimus · ╌ Ustekinumab
Source: NHSBSA Prescription Cost Analysis, to May 2026
| Measure | Pimecrolimus | Ustekinumab |
|---|---|---|
| Items, May 2026 | 12,797 | 1 |
| Items, last 12 months | 134,844 | 111 |
| Net ingredient cost, May 2026 | £364,789 | £2,147 |
See the full profile for Pimecrolimus or Ustekinumab.